Mackenzie Woestman Krone

Mackenzie Woestman Krone

Auto-generated profile, based on publicly available information

Mackenzie Woestman Krone

Department of Molecular, Cellular, and Developmental Biology, Yale University, 260 Whitney Ave, CT 06520-8103 New Haven, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2024 in Science Advances
Verified
Journal Article
Open access
ZHZhenyi Hu
Zhenyi Hu
Po-Han ChenPo-Han Chen
Po-Han Chen
WLWenxue Li
Wenxue Li
MKMackenzie Krone
Mackenzie Krone
SZSijin Zheng
Sijin Zheng
CCCraig M. Crews
Craig M. Crews
We recently developed a heterobifunctional approach [phosphorylation targeting chimeras (PhosTACs)] to achieve the targeted protein dephosphorylation (TPDephos). Here, we envisioned combining the inhibitory effects of receptor tyrosine kinase inhibitors (RTKIs) and the active dephosphorylation by phosphatases to achieve dual inhibition of kinases. We report an example of tyrosine phosphatase–based TPDephos and the effective epidermal growth factor receptor (EGFR) tyrosine dephosphorylation. We also used phosphoproteomic approaches to study the signaling transductions affected by PhosTAC-related molecules at the proteome-wide level. This work demonstrated the differential signaling pathways inhibited by PhosTAC compared with the TKI, gefitinib. Moreover, a covalent PhosTAC selective for mutated EGFR was developed and showed its inhibitory potential for dysregulated EGFR. Last, EGFR PhosTACs, consistent with EGFR dephosphorylation profiles, induced apoptosis and inhibited cancer cell viability during prolonged PhosTAC treatment. PhosTACs showcased their potential of modulating RTKs activity, expanding the scope of bifunctional molecule utility.

7 November 2017 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SBStefanie A. Baril
Stefanie A. Baril
AKAmber L. Koenig
Amber L. Koenig
MKMackenzie W. Krone
Mackenzie W. Krone
KAKatherine I. Albanese
Katherine I. Albanese
CHCyndi Qixin He
Cyndi Qixin He
EBEric M. Brustad
Eric M. Brustad

1 November 2019 in ACS Chemical Biology
Verified
Journal Article
Closed access
KAKatherine I. Albanese
Katherine I. Albanese
MKMackenzie W. Krone
Mackenzie W. Krone
CPChristopher J. Petell
Christopher J. Petell
MPMadison M. Parker
Madison M. Parker
Brian D. StrahlBrian D. Strahl
Brian D. Strahl
MWMarcey L. Waters
Marcey L. Waters

27 August 2024 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
KLKe Li
Ke Li
MKMackenzie W. Krone
Mackenzie W. Krone
ABArseniy Butrin
Arseniy Butrin
MBMichael J. Bond
Michael J. Bond
BLBrian M. Linhares
Brian M. Linhares
CCCraig M. Crews
Craig M. Crews

4 March 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
MKMackenzie W. Krone
Mackenzie W. Krone
KAKatherine I. Albanese
Katherine I. Albanese
GLGage O. Leighton
Gage O. Leighton
CHCyndi Qixin He
Cyndi Qixin He
GLGa Young Lee
Ga Young Lee
MWMarcey L. Waters
Marcey L. Waters
Evolution has converged on cation–π interactions for recognition of quaternary alkyl ammonium groups such as trimethyllysine (Kme3). While computational modelling indicates that Trp provides the strongest cation–π interaction of the native aromatic amino acids, there is limited corroborative data from measurements within proteins. Herein we investigate a Tyr to Trp mutation in the binding pocket of the HP1 chromodomain, a reader protein that recognizes Kme3. Binding studies demonstrate that the Trp-mediated cation–π interaction is about −5 kcal mol−1 stronger, and the Y24W crystal structure shows that the mutation is not perturbing. Quantum mechanical calculations indicate that greater enthalpic binding is predominantly due to increased cation–π interactions. NMR studies indicate that differences in the unbound state of the Y24W mutation lead to enthalpy–entropy compensation. These results provide direct experimental quantification of Trp versus Tyr in a cation–π interaction and afford insight into the conservation of aromatic cage residues in Kme3 reader domains.

19 June 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
AWAnnabelle C. Weldert
Annabelle C. Weldert
AFAriane F. Frey
Ariane F. Frey
MKMackenzie Woestman Krone
Mackenzie Woestman Krone
FKFranziska Krähe
Franziska Krähe
HKHannah Kuhn
Hannah Kuhn
FBFabian Barthels
Fabian Barthels
Iterative PROTAC design meets molecular fine-tuning—a medicinal chemistry journey to targeted METTL3 degradation.